In this study, the serum AST, ALT and ALP activities and hepatic TC and TG contents were significantly decreased by the EPS and DEPS treatments compared to the high-fat emulsion group, indicating that both EPS and DEPS potentially treated liver damage caused by hyperlipidaemia. This evidence concerns the gene GPT and hyperlipidemia.